Fortis presents $32.2 billion capital plan for 2027-2031
Bitget2026/11/03 11:25- Fortis outlined a $32.2 billion capital plan for 2027-2031, up $3.4 billion from its prior plan, driven by transmission and LNG investments.
- Projected five-year rate base growth accelerated to 7.5% annually, up 50 basis points from the prior plan.
- Annual dividend growth guidance of 4%-6% extends through 2031, following a 4% dividend increase in the fourth quarter of 2026.
- Cash from operations is expected to fund 57% of capital spending; net debt will cover 32%, with equity providing 11%.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
CleanSpark presents fully funded Sandersville project in investor presentation
Forge Nano completes acquisition of HzO
Crypto prices
More
